RTX

RTX has a high-quality, diversified aerospace and defense franchise across Collins Aerospace, Pratt & Whitney, and Raytheon, giving it scale advantages in platforms, spares, and long-duration programs. The demand backdrop remains favorable as governments push to expand munitions capacity, and RTX’s Raytheon agreements to grow critical production at multiple U.S. sites should reinforce customer embeddedness and program longevity. The key question for moat durability is whether Pratt & Whitney can steadily work through the geared turbofan (GTF) inspection/remediation workload without eroding customer trust and margins.

Financially, Q1 2026 showed strong execution: sales of $22.1B grew 9% year-over-year (10% organic) and RTX raised 2026 adjusted EPS guidance to $6.70–$6.90 while reaffirming free cash flow of $8.25B–$8.75B. Adjusted EPS in Q1 was reported around $1.78, implying solid year-over-year growth and improving operating leverage, but granular profitability and balance-sheet metrics are limited in the supplied dataset. Income investors should note the board declared a $0.68 quarterly dividend (about $2.72 annualized), though the exact current yield depends on price.

Over the next 12 months, the upside case is continued defense production ramp plus aftermarket strength translating backlog into cash, with guidance raises as supply-chain constraints ease. The main risks are GTF-related cost/compensation volatility and any knock-on effect to OEM build rates, plus potential program timing shifts in U.S. and allied budgets. With the stock near the upper end of its 52-week range, near-term returns likely hinge on incremental guidance and cash conversion rather than multiple expansion.

Recommendation: HOLD. The business momentum and raised 2026 outlook support downside protection, but unresolved GTF execution risk and a higher starting valuation versus last year’s lows temper the risk-adjusted 12-month upside.